2021
DOI: 10.20945/2359-3997000000368 View full text |Buy / Rent full text
|
|

Abstract: Objective: Adipose tissue-derived stromal/stem cells (ASCs) and vitamin D have immunomodulatory actions that could be useful for type 1 diabetes (T1D). We aimed in this study to investigate the safety and efficacy of ASCs + daily cholecalciferol (VIT D) for 6 months in patients with recent-onset T1D. Materials and methods: In this prospective, dual-center, open trial, patients with recent onset T1D received one dose of allogenic ASC (1 x 10 6 cells/kg) and cholecalciferol 2,000 UI/day for 6 months (group 1). T… Show more

Help me understand this report

Search citation statements

Order By: Relevance
Select...
0
4
0

Publication Types

Select...

Relationship

0
0

Authors

Journals